Karen Foster
Net Worth
Last updated:
What is Karen Foster net worth?
The estimated net worth of Ms. Karen Foster is at least $8,989,038 as of 26 Nov 2024. She owns shares worth $3,848,978 as insider, has earned $3,411,410 from insider trading and has received compensation worth at least $1,728,650 in BioLife Solutions, Inc..
What is the salary of Karen Foster?
Ms. Karen Foster salary is $345,730 per year as Chief Quality Officer in BioLife Solutions, Inc..
How old is Karen Foster?
Ms. Karen Foster is 65 years old, born in 1960.
What stocks does Karen Foster currently own?
As insider, Ms. Karen Foster owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| BioLife Solutions, Inc. (BLFS) | Chief Quality Officer | 156,973 | $24.52 | $3,848,978 |
What does BioLife Solutions, Inc. do?
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Karen Foster insider trading
BioLife Solutions, Inc.
Ms. Karen Foster has made 69 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently she sold 252 units of BLFS stock worth $6,854 on 26 Nov 2024.
The largest trade she's ever made was exercising 38,836 units of BLFS stock on 12 Apr 2022. As of 26 Nov 2024 she still owns at least 156,973 units of BLFS stock.
BioLife Solutions key executives
BioLife Solutions, Inc. executives and other stock owners filed with the SEC:
- Dr. Aby J. Mathew (53) Chairman of Scientific Advisory Board, Executive Vice President & Chief Scientific Officer
- Mr. Michael P. Rice (62) Chairman & Chief Executive Officer
- Mr. Roderick de Greef (65) Pres & Chief Operating Officer
- Mr. Todd Berard (56) Chief Marketing Officer
- Ms. Karen Foster (65) Chief Quality Officer